Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories (NYSE:ABT) will release earnings results for the second quarter, before the opening bell on Thursday, July 17.

Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.25 per share, up from $1.14 per share in the year-ago period. Abbott Laboratories projects to report quarterly revenue at $11.02 billion, compared to $10.38 billion a year earlier, according to data from Benzinga Pro.

On May 27, Abbott announced the U.S. Food and Drug Administration approved the company’s Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease.

Abbott Laboratories shares rose 0.1% to close at $131.49 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, ...